← Leaderboards
Lawrence H Boise
University Of Miami School Of Medicine
$10,842,636
Attributed
$12,964,542
Total exposure
10
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $976.1K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,964,542 · 10
By mechanism
R01$7,587,170 · 5
T32$4,243,813 · 2
P30$411,086 · 1
R21$398,010 · 1
R29$324,463 · 1
Top collaborators
- Anita H Corbett13 shared
Most similar at University Of Miami School Of Medicine
Same institution · by research overlap
- Midhat H Abdulreda$2,833,074
- Paolo Serafini$2,304,023
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsMalignant NeoplasmsApoptosisCell DeathMultiple MyelomaBaseBone MarrowPathway InteractionsTraining ProgramsDesignCell KillingApoptoticResponseProteinsPlasma CellsSignal TransductionDrug ResistanceBiochemistryCell LineProteasome InhibitionProteasome InhibitorPharmaceutical PreparationsEventAntibodies
Grant awards (46)
Training Program in Biochemistry, Cell and Development Biology$426,360
T32 · FY2025 · GM · contact PI
Cancer Research Training & Education Coordination$258,891
P30 · FY2025 · CA · contact PI
Training Program in Biochemistry, Cell and Development Biology$376,541
T32 · FY2024 · GM · contact PI
Cancer Research Training & Education Coordination$77,017
P30 · FY2024 · CA · contact PI
Training Program in Biochemistry, Cell and Development Biology$424,428
T32 · FY2023 · GM · contact PI
Defining the landscape of structural alterations in African American Multiple Myeloma$215,101
R21 · FY2023 · CA · contact PI
Cancer Research Training & Education Coordination$75,178
P30 · FY2023 · CA · contact PI
Training Program in Biochemistry, Cell and Development Biology$364,253
T32 · FY2022 · GM · contact PI
Defining the landscape of structural alterations in African American Multiple Myeloma$182,909
R21 · FY2022 · CA · contact PI
Training Program in Biochemistry, Cell and Development Biology$341,340
T32 · FY2021 · GM · contact PI
Training Program in Biochemistry, Cell and Molecular Biology$72,170
T32 · FY2021 · GM · contact PI
The Role of CD86 in Multiple Myeloma$342,896
R01 · FY2020 · CA · contact PI
Training Program in Biochemistry, Cell and Development Biology$337,439
T32 · FY2020 · GM · contact PI
The Role of CD86 in Multiple Myeloma$334,838
R01 · FY2019 · CA · contact PI
TRAINING PROGRAM IN BIOCHEMISTRY, CELL AND DEVELOPMENT BIOLOGY$316,162
T32 · FY2019 · GM · contact PI
The Role of CD86 in Multiple Myeloma$167,666
R01 · FY2019 · CA · contact PI
The Role of CD86 in Multiple Myeloma$347,673
R01 · FY2018 · CA · contact PI
TRAINING PROGRAM IN BIOCHEMISTRY, CELL AND DEVELOPMENT BIOLOGY$329,909
T32 · FY2018 · GM · contact PI
The Role of CD86 in Multiple Myeloma$348,359
R01 · FY2017 · CA · contact PI
TRAINING PROGRAM IN BIOCHEMISTRY, CELL AND DEVELOPMENT BIOLOGY$326,281
T32 · FY2017 · GM · contact PI
Novel Roles for Effector Procaspases$296,400
R01 · FY2017 · GM · contact PI
The Role of CD86 in Multiple Myeloma$356,973
R01 · FY2016 · CA · contact PI
TRAINING PROGRAM IN BIOCHEMISTRY, CELL AND DEVELOPMENT BIOLOGY$322,743
T32 · FY2016 · GM · contact PI
Novel Roles for Effector Procaspases$296,400
R01 · FY2016 · GM · contact PI
TRAINING PROGRAM IN BIOCHEMISTRY, CELL AND DEVELOPMENT BIOLOGY$319,295
T32 · FY2015 · GM · contact PI
Novel Roles for Effector Procaspases$296,400
R01 · FY2015 · GM · contact PI
Novel Roles for Effector Procaspases$296,400
R01 · FY2014 · GM · contact PI
Training Program in Biochemistry, Cell and Molecular Biology$286,892
T32 · FY2014 · GM · contact PI
Arsenic-induced apoptosis in myeloma$341,076
R01 · FY2013 · CA · contact PI
Arsenic-induced apoptosis in myeloma$362,855
R01 · FY2012 · CA · contact PI
Proteosome inhibitor sensitivity in multiple myeloma: The role of ER stress$311,976
R01 · FY2012 · CA · contact PI
Arsenic-induced apoptosis in myeloma$362,853
R01 · FY2011 · CA · contact PI
Proteosome inhibitor sensitivity in multiple myeloma: The role of ER stress$311,976
R01 · FY2011 · CA · contact PI
Arsenic-induced apoptosis in myeloma$387,826
R01 · FY2010 · CA · contact PI
Proteosome inhibitor sensitivity in multiple myeloma: The role of ER stress$321,625
R01 · FY2010 · CA · contact PI
Arsenic-induced apoptosis in myeloma$383,922
R01 · FY2009 · CA · contact PI
Proteosome inhibitor sensitivity in multiple myeloma: The role of ER stress$197,475
R01 · FY2009 · CA · contact PI
Proteosome inhibitor sensitivity in multiple myeloma: The role of ER stress$121,568
R01 · FY2009 · CA · contact PI
Proteosome inhibitor sensitivity in multiple myeloma: The role of ER stress$317,475
R01 · FY2008 · CA · contact PI
Caspase-activated mitochondrial depolarization$266,292
R01 · FY2006 · GM · contact PI
Caspase-activated mitochondrial depolarization$272,700
R01 · FY2005 · GM
Caspase-activated mitochondrial depolarization$272,700
R01 · FY2004 · GM
Caspase-activated mitochondrial depolarization$270,846
R01 · FY2003 · GM
MECHANISM OF BCL-X EXPRESSION IN LYMPHOCYTES AND CANCER$110,724
R29 · FY2002 · CA
MECHANISM OF BCL-X EXPRESSION IN LYMPHOCYTES AND CANCER$108,130
R29 · FY2001 · CA
MECHANISM OF BCL-X EXPRESSION IN LYMPHOCYTES AND CANCER$105,609
R29 · FY2000 · CA